Ccl2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CCL2 (C-C Motif Chemokine Ligand 2), also known as MCP-1 (Monocyte Chemoattractant Protein-1), is a key chemokine that plays a central role in immune cell recruitment to sites of inflammation. In the central nervous system, CCL2 is produced by neurons, astrocytes, and microglia in response to injury, infection, or disease, making it a critical mediator of neuroinflammation.
Elevated CCL2 levels have been documented in the brains and cerebrospinal fluid of patients with Alzheimer's Disease, Parkinson's Disease, and multiple sclerosis. The CCL2-CCR2 signaling axis represents a major pathway for monocyte and microglia recruitment to neurodegenerating brain regions, contributing to both protective immune surveillance and pathological neuroinflammation.
CCL2 (also known as MCP-1, Monocyte Chemoattractant Protein-1) is a member of the CC chemokine family. It is a potent chemoattractant for monocytes, microglia, and other immune cells. In the brain, CCL2 is produced by neurons, astrocytes, and microglia in response to injury or disease, recruiting immune cells to sites of neurodegeneration.
CCL2 is expressed in:
High expression in hippocampus, cortex, and basal ganglia.
The study of Ccl2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918-934. DOI:10.1016/j.cell.2010.02.016
Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388-405. DOI:10.1016/S1474-4422(1570016-5
Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777-783. DOI:10.1126/science.aag2590
Song WM, Colonna M. The identity and function of microglia in neurodegeneration. Nat Immunol. 2018;19(10):1048-1058. DOI:10.1038/s41590-018-0212-1
Wolf Y, Yona S, Kim KW, Jung S. Microglia, seen from the TNF side. Nat Rev Immunol. 2017;17(1):49. DOI:10.1038/nri.2016.144
Prinz M, Priller J. The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci. 2017;20(2):136-144. DOI:10.1038/nn.4475
Deczkowska A, Amit I, Schwartz M. Microglial immune checkpoint mechanisms. Nat Neurosci. 2018;21(6):779-781. DOI:10.1038/s41593-018-0144-y
Keren-Shaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer's disease. Cell. 2017;169(7):1276-1290.e17. DOI:10.1016/j.cell.2017.05.018